Menu
Live
Market Overview
Live indices, gainers & losers
Market Pulse
AI-curated live updates
Market Movers
Top gainers & losers by cap
Market Signals
Value, momentum & analyst signals
Smart Money
Insider & congress trades
Hedge Funds
What 63 elite funds bought & sold
52-Week Highs
Stocks breaking out to new highs
52-Week Lows
Beaten-down stocks near support
High Beta
Stocks that move more than the market
Earnings Calendar
Upcoming earnings dates
Daily
Research
Invest
LIVE
Sanofi
SNY
NASDAQ·Healthcare·Drug Manufacturers - General·Mkt cap $100.1B
$43.16
▲ +3.68%
View full research view
Our plain-language verdict, the thesis, risk factors, and what is changing about the business.
View research view52-Week Range
$40.89 - $52.68
P/E
Fwd P/E
Beta
Div Yield
Avg Vol
Shares Out
Mkt Cap
Price action
Price chart
Down 15.6% over the trailing year
Total returns
Price performance
Total return across standard periods - splits & dividends adjusted by FMP. Periods longer than 1Y show annualized in the tooltip.
Why we rate it this way
The thesis at a glance
Bull and bear case · plain-English context across the five lenses we evaluate.
Bull Case
No bull reasons captured for this rating yet.
Bear Case
1 risk
- Low volatility (beta 0.3).
Growth
Stable outlook
Value
Deep value opportunity - significant discount to sector peers
Momentum
Weak
-13.1% over 3m
Quality
Excellent
Excellent business quality
Dividend
High yield
5.64% yield
Smart-money signal
Who's buying SNY right now
Insider Form 4s, 13F institutional filings, and Congressional disclosures - at a glance.
Earnings track record
Recent earnings results
AI-summarized recap of last quarter, plus the surprise on every print.
Next: Jul 30, 2026
Earnings recap unavailable for this period.
EPS surprise · last 4Q
Q1 26
$0.67
Q4 25
-$1.48
Q3 25
$1.15
Q2 25
$1.60
Next: Jul 30, 2026
Revenue trend · last 8Q
—
—
—
—
-6%
-7%
+60%
+6%
Q2 24
Q3 24
Q4 24
Q1 25
Q2 25
Q3 25
Q4 25
Q1 26
$11.4B
$14.2B
$7.6B
$10.6B
$10.7B
$13.2B
$12.2B
$11.2B
Margins · last 8Q
Gross
72.1%
Operating
20.2%
Profit
14.3%
Wall Street consensus
2 analysts · 0% Buy
Live ratings and price targets aggregated across covering analysts.
Buy
0%
Hold
100%
Sell
0%
Median Price Target
$51.00
▲ +18.2% vs $43.16
Latest: Morgan Stanley · $52.00 · May 1, 2026
2 analysts covering
vs Industry
How SNY stacks vs Drug Manufacturers - General
Stock metrics vs industry averages. Green = better than industry.
Industry comparison data unavailable for this stock.
Related
Peers & themes
Peers
No peer data available.
Themes
No themes assigned.